THE ENLIGHTEN STUDY

NACompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

May 1, 2019

Study Completion Date

May 1, 2019

Conditions
ObesityOverweight
Interventions
DEVICE

Active Elipse Device

Intervention Device

DEVICE

Elipse Sham Device

Control Device

Trial Locations (12)

10065

Weill Cornell Medicine, Division of Endocrinology, Diabetes and Metabolism, New York

15213

University of Pennsylvania Medical Center (UPMC), Pittsburgh

22291

Charlottesville Medical Research Center, Charlottesville

37204

Vanderbilt Center for Surgical Weight Loss, Nashville

37421

CHI Metabolic and Bariatric Care, Chattanooga

38120

MidSouth Bariatrics, Memphis

60440

Bariatric Institute of Greater Chicago, Bolingbrook

70001

Surgical Specialists of Louisiana, Metairie

77401

UT Physicians Minimally Invasive Surgeons of Texas (UTMIST), Bellaire

80045

University of Colorado, Anschutz Health and Wellness Center, Aurora

85258

Honor Health, Scottsdale

01002

Holyoke Medical Center, Holyoke

Sponsors
All Listed Sponsors
lead

Allurion Technologies

INDUSTRY

NCT03261453 - THE ENLIGHTEN STUDY | Biotech Hunter | Biotech Hunter